THOP1 and Other metabolic disease: Although there is no concrete evidence, neurolysin is hypothesized to be involved in the pathology of human diseases such as epilepsy, angiogenesis, tumor growth, sepsis, stroke, and metabolic disorder, together with thimet oligopeptidase (THOP1) and a POP [132].